Currency In USD
| Previous Close | 4.51 |
| Open | 4.42 |
| Day High | 4.54 |
| Day Low | 4.25 |
| 52-Week High | 16.16 |
| 52-Week Low | 3 |
| Volume | 241,433 |
| Average Volume | 209,877 |
| Market Cap | 83.6M |
| PE | -1.41 |
| EPS | -3.2 |
| Moving Average 50 Days | 4.57 |
| Moving Average 200 Days | 4.72 |
| Change | 0 |
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
GlobeNewswire Inc.
Jan 27, 2026 2:00 PM GMT
Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
GlobeNewswire Inc.
Jan 26, 2026 9:05 PM GMT
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will rel
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 1:30 PM GMT
Appoints Medical Technology Veteran Karen N. Prange to Board of DirectorsSAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and co